Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study

por Rutherford, Ole-Christian W, Jonasson, Christian, Ghanima, Waleed, Söderdahl, Fabian, Halvorsen, Sigrun
Publicado 2020